Posted on July 24, 20247/24/24
Evolving Standards: NICE’s Enhanced RWE Framework for Global Data Transportability
Posted on July 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on July 2, 20247/2/24
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach
Posted on April 30, 20244/30/24
Decoding EMA’s Blueprint on Real-World Evidence
Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on July 26, 20237/26/23
The Role of RWE in Expediting the Drug Approval Process
Posted on July 4, 20237/4/23
A Comparison of Existing Real World Evidence (RWE) Guidelines
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on May 15, 20235/15/23
Role of Decentralized Trials for Newer Drug Approvals
Posted on April 17, 20234/17/23